FDA Inspection
Samsung Biologics Co., Ltd.Samsung Biologics Co., Ltd. – FDA Inspection, May 27, 2025
Record Details
This FDA Inspection record concerns Samsung Biologics Co., Ltd., with an inspection on May 27, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · d20015df-a132-4e1e-be47-84e8a2b9ad6f
Inspection Facts
- Inspection number
- 1269570
- FDA center
- Biologics
Other FDA inspections of Samsung Biologics Co., Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2024 | Not classified | Office of Inspections and Investigations | |
| September 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 10, 2019 | Not classified | Office of Inspections and Investigations |
Other documents for Samsung Biologics Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.